Intestinal <i>Bacteroides</i> modulates inflammation, systemic cytokines, and microbial ecology via propionate in a mouse model of cystic fibrosis
Courtney E. Price, Rebecca A. Valls, Alexis R. Ramsey, Nicole A. Loeven, Jane T. Jones, Kaitlyn E. Barrack, Joseph D. Schwartzman, Darlene B. Royce, Robert A. Cramer, Juliette C. Madan, Benjamin D. Ross, James B. Bliska, George A. O’Toole
Abstract
The composition of the gut microbiome in persons with CF is correlated with lung health outcomes, a phenomenon referred to as the gut-lung axis. Here, we demonstrate that the intestinal microbe Bacteroides decreases inflammation through the production of the short-chain fatty acid propionate. Supplementing the levels of Bacteroides in an animal model of CF is associated with reduced systemic inflammation and reduction in the relative abundance of the opportunistically pathogenic group Escherichia / Shigella in the gut. Taken together, these data demonstrate a key role for Bacteroides and microbially produced propionate in modulating inflammation, gut microbial ecology, and the gut-lung axis in cystic fibrosis. These data support the role of Bacteroides as a potential probiotic in CF.